Apollo Hospitals’ Q2FY25 Results
- 07 Nov 2024
- Apollo Hospitals reported a 9.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter ended Sept (Q2FY25). On a year-on-year (YoY) basis, it witnessed a growth of 15.6%.
- Its expenses for the quarter were up by 7.9% QoQ and 12.9% YoY.
- The net profit increased 25.4% QoQ and 59% YoY.
- The earnings per share (EPS) of Apollo Hospitals stood at 26.3 during Q2FY25.
Apollo Hospitals’ Financial Statements for Q2FY25:
| (₹ crores) | Q2FY24 | Q1FY25 | Q2FY25 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total income | 4,869 | 5,123 | 5,628 | 9.9% | 15.6% |
Total expenses | 4,494 | 4,704 | 5,076 | 7.9% | 12.9% |
Profit before tax | 379 | 430 | 557 | 29.6% | 47.1% |
Tax | 130 | 115 | 162 | 41.2% | 24.2% |
Profit after tax | 249 | 316 | 396 | 25.4% | 59.0% |
Earnings per share | 16.2 | 21.2 | 26.3 |
Financials:
Revenue: Total Revenue ₹5,589 Crores, up 15% YoY.
EBITDA: ₹816 Crores, up 30% YoY.
Profit after Tax (PAT): ₹379 Crores, up 63% YoY from ₹233 Crores in Q2 FY24.
Management Commentary:
Dr. Prathap C. Reddy, Founder & Chairman of Apollo Hospitals Group:
- Commitment to Healthcare Access: Apollo Hospitals is dedicated to meeting the evolving healthcare needs of India through investments in Apollo Health and Lifestyle and new multi-specialty hospitals, particularly in critical access regions.
- Notable Partnership: Recently partnered with the Government of Tripura to provide free heart surgeries for children, emphasizing the goal of accessible healthcare for underserved communities.
- Advancements in Medical Technology: Introducing innovative treatments like water vapor thermotherapy for prostate care and robotic radiosurgery systems for cancer to make procedures less invasive and improve patient recovery.
- Investment in Medical Research: Launching a new research academy focused on groundbreaking medical discoveries to shape the future of healthcare and treatments.
- Mission for the Future: Aiming to expand the reach and impact of healthcare services, ensuring that everyone has access to quality medical care regardless of location. This aligns with Apollo's mission to push the boundaries of healthcare and provide the best medical services.
- Outlook for FY25: Marked as an exciting time with milestones in extending healthcare impact, reaffirming Apollo's commitment to innovation, safety, and advancing medical science.
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
FAQs
When was Apollo Hospitals Q1 FY 2025-26 result announced?
Apollo Hospitals announced its Q1 FY 2025-26 results on 14 August, 2025.
What are Apollo Hospitals quarterly results?
Apollo Hospitals quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
What were the key highlights of Apollo Hospitals Q1 FY 2025-26 results?
Key highlights of Apollo Hospitals Q1 FY 2025-26 results include:
- Revenue: ₹5882.30 crore
- Net Profit: ₹441.00 crore
- EBITDA: ₹892.10 crore
- Year-over-Year Growth: 14.8%
- Quarter-over-Quarter Growth: 18.3%
How did Apollo Hospitals net profit perform in this quarter?
Apollo Hospitals reported a net profit of ₹441.00 crore in Q1 FY 2025-26, reflecting a 39.8% year-over-year growth.
What was Apollo Hospitals revenue in Q1 FY 2025-26?
Apollo Hospitals posted a revenue of ₹5882.30 crore in Q1 FY 2025-26.